Partnership Opportunities

Partner With Us

After decades of unfulfilled potential, the commercial reality of gene therapies is rapidly taking shape. This is most evident perhaps in the blood disorders space, being home to a number of the leading candidates under the gene therapy umbrella and most likely the indication we will see the fields next approval in.

In light of this, more gene therapy drug developers are establishing a presence in the blood disease space. These therapies cannot be pioneered without the important services that top solution providers offer - from high-quality diagnostics and coagulation services to ensuring drug developers stand out from the crowd, to exceptional clinical trials run by experts in blood disease.

Having conducted extensive research with Gene Therapy BioPharma we are repeatedly being told that there is a major bottleneck in the blood disorders space in terms of high quality, efficient and effective service providers with whom they can work.

In our first “in-person” meeting within this field since 2019 we are set to unite 100+ clinical, translational, safety and commercial industry experts from the fields leading companies in Boston in March 2022. From extensive research with these organisations, we are aware that they are all actively seeking to collaborate with organizations that can help them solve their drug development challenges.

If you are a contract service provider with expertise in the gene therapy space who can meet these exploding markets’ demands, then The Gene Therapy for Blood Disorders Summit will provide a platform for you to showcase your solutions to a niche audience of experts from the leading gene therapy developers.

We have a limited number of partnership opportunities available, including speaking positions across our agenda.

Why Partner?

Showcase your expertise to leading organizations by securing an exhibition booth

Secure a spot on our expert speaker faculty to demonstrate thought leadership and drive brand exposure

Maximize the balance of 2:1 live content and targeted networking to generate leads and build new relationships with analytical pioneers

Embrace the tech to meet your 2021 commercial objectives and educate decision-makers on how your expertise can deliver gene therapies to patients more effectively

Gtx grpah 1
Gtx grpah 2

Email us at for more information about the digital partnership opportunities available which will deliver on your commercial objectives in 2022 and beyond. Act now to stay ahead of the curve and seize the wealth of opportunity on offer.